Google AI
The Times Australia
News From Asia

.

Takeda Ukraine & Bulgaria Earn #8 Global Ranking in Best Places to Work 2024

LONDON, UK - Media OutReach Newswire - 5 June 2025 - Takeda, a global value-based, R&D-driven biopharmaceutical company, has been proudly recognized as one of the Top 10 Best Places to Work in the World for 2024, achieving the No.

8 global ranking by both Ukraine and Bulgaria countries. This prestigious recognition underscores Takeda's commitment to creating a workplace that embraces diversity, equity and inclusion (DE&I), fostering an empowering culture across all locations it operates. This accolade reflects Takeda's consistent focus on employee well-being, trust-based leadership, and a people-centered approach to business.

At Takeda, we are committed to delivering an exceptional employee experience by cultivating an inclusive, purpose-driven workplace where our people can grow both personally and professionally. Being recognized as a Best Place to Work reflects our unwavering dedication to building a culture where every colleague feels valued, supported, and empowered to thrive.

Volodymyr Pedko, General Manager of Takeda Ukraine, shared:
"It gives me great pride to receive this recognition during such challenging times! It stands as a testament to the exceptional quality of work and everyone's commitment to building and sustaining an innovative and inclusive workplace in our organization."

Todor Kesimov, General Manager of Takeda Romania & Bulgaria, commented:
"I am extremely proud that Takeda has been recognized as one of the top ten employers in the world for 2024. This confirms our efforts to build a culture of trust, care, and respect in every country, including Bulgaria. This recognition inspires us to continue building a better future – for our employees, for patients, and for society."
Hashtag: #BestPlacesToWork


The issuer is solely responsible for the content of this announcement.

About Takeda

Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries. For more information, visit .

For more information, please visit the program website: .

Times Magazine

CRO Tech Stack: A Technical Guide to Conversion Rate Optimization Tools

The fascinating thing is that the value of this website lies in the fact that creating a high-cali...

How Decentralised Applications Are Reshaping Enterprise Software in Australia

Australian businesses are experiencing a quiet revolution in how they manage data, execute agreeme...

Bambu Lab P2S 3D Printer Review: High-End Performance Meets Everyday Usability

After a full month of hands-on testing, the Bambu Lab P2S 3D printer has proven itself to be one...

Nearly Half of Disadvantaged Australian Schools Run Libraries on Less Than $1000 a Year

A new national snapshot from Dymocks Children’s Charities reveals outdated books, no librarians ...

Growing EV popularity is leading to queues at fast chargers. Could a kerbside charger network help?

The war on Iran has made crystal clear how shaky our reliance on fossil fuels is. It’s no surpri...

TRUCKIES UNDER THE PUMP AS FUEL PRICES BECOME TWO THIRDS OF OPERATING COSTS FOR SOME BUSINESS OWNERS

As Australia’s fuel crisis continues, truck drivers across the nation are being hit hard despite t...

The Times Features

City of Sydney’s Australian Life photography competitio…

Focus on Australian life unfiltered  Amateur and professional photographers from across the count...

SWEET Announce ''The Final Blitz'' Australian Tour

Chanted vocals. Pounding drums. Infectious guitar riffs. Led by legendary guitarist Andy Scott...

Atlassian: What It Is, What It Does and Who Runs It

In an era where global technology giants are dominated by Silicon Valley, one of the most influe...

Mortgage Stress – it is happening. Here is what is driv…

Mortgage stress is no longer a fringe issue confined to a small group of overextended borrowers...

Mortgage Lending in Australia: Brokers vs Banks — Trust…

For most Australians, taking out a mortgage is the single largest financial decision they will e...

Building Costs in Australia: Permits, Taxes, Contributi…

Australia’s housing debate is often framed around supply and demand, interest rates, and populat...

Airfares: What the Iran Disarmament Campaign Means for …

For Australians planning their next interstate getaway or long-awaited overseas holiday, the cos...

Interest-free loans needed for agriculture amid fuel cr…

The Albanese Government should release the details of its plan to provide interest-free loans to b...

Next stage of works to modernise Port of Devonport

TasPorts is progressing the next stage of its QuayLink program at the Port of Devonport, with up...